The funding will be used to expand the adoption of the Cionic Neural Sleeve for individuals with impaired mobility. Credit: Juan Ci / Shutterstock.com.

Neurotech company CIONIC has raised an additional $12m in Series A extension financing for its Neural Sleeve.

The Series A financing now stands at $25m following the latest funding round.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Led by L Catterton, the round saw participation from an additional new investor THVC and all key investors. Furthermore, the company has collaborated with Enable Ventures.

Whitney Casey, an entrepreneur and venture partner, has joined CIONIC’s board of directors as part of L Catterton’s investment.

The funds will be used to expand the adoption of the Cionic Neural Sleeve to address the impaired mobility challenges of individuals with conditions like strokes, multiple sclerosis, cerebral palsy and other neurological disorders.

The Cionic Neural Sleeve can analyse and increase human movement, allowing the body to move with more freedom and control than with walkers, crutches, or wheelchairs.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

It integrates the diagnostic capabilities of a gait lab with the healing potential of functional electrical stimulation (FES) into a lightweight and wearable garment suitable for use in any setting.

CIONIC also intends to utilise the funds to expedite its product pipeline into new indications to address the full spectrum of human mobility.

It has obtained a licence to ship the Cionic Neural Sleeve in 45 US states, partnering with more than 400 prescribing institutions.

CIONIC founder and CEO Jeremiah Robison said: “Our partners recognise that we are building something truly unique and we are proud to work with organisations who share not only our vision for the future of healthcare but whose deep expertise in brand building, healthcare transformation and disability advocacy will help us accelerate the timeline for making this vision a reality.”

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact